Warfarin Sensitivity Genotyping: A Review of the Literature and Summary of Patient Experience
- Neue Antikoagulanzien, neue NotfÃ¤lle? Djalali, Sima // Praxis (16618157);7/24/2013, Vol. 102 Issue 15, p945
No abstract available.
- Oral Vitamin K for Excessive Anticoagulation. Artz, Andrew S. // Clinical Oncology Alert;Apr2009, Vol. 25 Issue 4, p25
Warfarin is a frequently prescribed oral anticoagulant. The highly variable, dose-response characteristics mandate monitoring, and this is usually accomplished by targeting an international normalized ratio (INR) value between 2.0 to 3.0. Non-therapeutic values are common, and values above 4.5...
- The progress of prothrombin time measurement. Horsti, Juha // Hematology Reviews;2009, Vol. 1 Issue 2, p99
Warfarin is the most widely used medicine for oral anticoagulant therapy (OAT). It inhibits the synthesis of coagulation factors II, VII, IX, and X in the liver and results in the production of inactive or partially active versions of these factors. Inactive coagulation factors interfere with...
- Independent Nurse: Clinical Top 50 - Oral anticoagulation. Provan, Drew // GP: General Practitioner;12/2/2005, p121
This article reports that therapeutic anticoagulation is increasing by 20 percent each year. By 1996, more than 300,000 British patients required oral anticoagulation. It is informed that warfarin is the preferred oral anticoagulant; phenindione is used in cases of warfarin allergy. Oral...
- Practical management of coagulopathy associated with warfarin. Garcia, David; Crowther, Mark A.; Ageno, Walter // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;4/24/2010, Vol. 340 Issue 7752, p918
The article discusses a practical management strategy for a patient with coagulopathy associated with warfarin. It cites several clinical questions that emerge when patients who take vitamin K antagonists are suffering from bleeding or having an international normalised ratio above the...
- Anticoagulant-related bleeding: into the unknown? Key, Nigel S. // Hem/Onc Today;6/25/2008, Vol. 9 Issue 11, p4
The author reflects on the issue of major bleeding associated with anticoagulation therapy and the search for the perfect coagulant. He enumerates the characteristics of the ideal anticoagulant proposed by several researchers. He examines the advantages of the anticoagulant warfarin over other...
- Rectus sheath hematoma in elderly, medical or surgical treatment? Marti, Juan // Internet Journal of Internal Medicine;2009, Vol. 8 Issue 1, p18
Anticoagulation induced bleeding complications to occur more frequently in the elderly. Two patients with Rectus sheath hematoma as a result of bleeding complication of warfarine therapy are reported.
- Fondaparinux or Enoxaparin for Deep Venous Thrombosis? // Annals of Internal Medicine;6/1/2004, Vol. 140 Issue 11, p44
This article presents information on the use of fondaparinux or enoxaparin for deep venous thrombosis. Deep venous thrombosis (DVT) is caused by a blood clot inside the deep veins of the legs. Pieces of the clot can break off, travel to the lungs, and cause serious and even fatal complications....
- VKORC1 Gene Analysis of Some Iranian Sensitive Patients to Warfarin. Kianmehr, Z.; Ghadam, P.; Sadrai, S.; Kazemi, B.; Sharifian, R. A. // Pakistan Journal of Biological Sciences;2010, Vol. 13 Issue 18, p906
No abstract available.